Results

Stealth BioTherapeutics Corp.

05/23/2022 | Press release | Distributed by Public on 05/23/2022 05:38

Stealth BioTherapeutics Announces Data from the Phase 2 ReCLAIM-2 Study of Elamipretide in Geographic Atrophy at the Clinical Trials at the Summit Meeting 2022